INTERNATIONAL PATENT: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, UNIVERSITE DE LILLE, CENTRE HOSPITALIER UNIVERSITAIRE DE LILLE FILES APPLICATION FOR "TARGETING HLA-H OR HLA-J SPECIFIC PEPTIDES FOR TREATING TRIPLE NEGATIVE BREAST CANCER"

GENEVA, March 23 -- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101 rue de Tolbiac75013 PARIS), UNIVERSITE DE LILLE (42 rue Paul Duez59800 LILLE), CENTRE HOSPITALIER UNIVERSITAIRE DE LILLE (2 avenue Oscar Lambret59000 LILLE) filed a patent application (PCT/IB2024/000501) for "TARGETING HLA-H OR HLA-J SPECIFIC PEPTIDES FOR TREATING TRIPLE NEGATIVE BREAST CANCER" on Sep 11, 2024. With publication no. WO/2026/058015, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SALZET, Michel (Laboratoire PRISM UMR1192 (Ins...